OncoMatch/Clinical Trials/NCT06798922
Flap Sparing in Postoperative Radiotherapy of Oral Cavity Cancers
Is NCT06798922 recruiting? Yes, currently enrolling (Jun 2026). This Phase 3 trial studies non-drug interventions for oral cavity carcinoma.
Patients with oral cavity cancer treated by reconstructive surgery with a flap. Patients will be treated in the study for : * Experimental arm: Post-operative radiotherapy with flap sparing * Control arm: Standard post-operative radiotherapy without flap sparing (current practice) Radiotherapy by IMRT using photons or proton therapy (IMPT)
Check if I qualifyExtracted eligibility criteria
Performance status
ECOG 0–2(Ambulatory, capable of self-care)
Prior therapy
Must have received: reconstructive surgery with a flap
treated by reconstructive surgery with a flap
Cannot have received: radiotherapy of head and neck area
History of radiotherapy of head and neck area
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT06798922 currently recruiting?
Yes, this trial is currently recruiting patients.
Are there prior therapy exclusions?
Yes. Prior radiotherapy of head and neck area disqualifies patients from enrollment.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify